BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38055287)

  • 1. Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls.
    Zhao X; Yang M; Fan J; Wang M; Wang Y; Qin N; Zhu M; Jiang Y; Gorlova OY; Gorlov IP; Albanes D; Lam S; Tardón A; Chen C; Goodman GE; Bojesen SE; Landi MT; Johansson M; Risch A; Wichmann HE; Bickeböller H; Christiani DC; Rennert G; Arnold SM; Brennan P; Field JK; Shete S; Le Marchand L; Liu G; Hung RJ; Andrew AS; Kiemeney LA; Zienolddiny S; Grankvist K; Johansson M; Caporaso NE; Woll PJ; Lazarus P; Schabath MB; Aldrich MC; Patel AV; Davies MPA; Ma H; Jin G; Hu Z; Amos CI; Shen H; Dai J
    Cancer; 2024 Mar; 130(6):913-926. PubMed ID: 38055287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylome analysis identifies BMI-related epigenetic changes associated with non-small cell lung cancer susceptibility.
    Li G; Meng H; Bai Y; Wei W; Feng Y; Li M; Li H; He M; Zhang X; Wei S; Li Y; Guo H
    Cancer Med; 2021 Jun; 10(11):3770-3781. PubMed ID: 33939316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically Predicted Levels of DNA Methylation Biomarkers and Breast Cancer Risk: Data From 228 951 Women of European Descent.
    Yang Y; Wu L; Shu XO; Cai Q; Shu X; Li B; Guo X; Ye F; Michailidou K; Bolla MK; Wang Q; Dennis J; Andrulis IL; Brenner H; Chenevix-Trench G; Campa D; Castelao JE; Gago-Dominguez M; Dörk T; Hollestelle A; Lophatananon A; Muir K; Neuhausen SL; Olsson H; Sandler DP; Simard J; Kraft P; Pharoah PDP; Easton DF; Zheng W; Long J
    J Natl Cancer Inst; 2020 Mar; 112(3):295-304. PubMed ID: 31143935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation markers of early-stage non-small cell lung cancer.
    Lokk K; Vooder T; Kolde R; Välk K; Võsa U; Roosipuu R; Milani L; Fischer K; Koltsina M; Urgard E; Annilo T; Metspalu A; Tõnisson N
    PLoS One; 2012; 7(6):e39813. PubMed ID: 22768131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide analysis of DNA methylation in bronchial washings.
    Um SW; Kim Y; Lee BB; Kim D; Lee KJ; Kim HK; Han J; Kim H; Shim YM; Kim DH
    Clin Epigenetics; 2018; 10():65. PubMed ID: 29796116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying CpG methylation signature as a promising biomarker for recurrence and immunotherapy in non-small-cell lung carcinoma.
    Luo R; Song J; Xiao X; Xie Z; Zhao Z; Zhang W; Miao S; Tang Y; Ran L
    Aging (Albany NY); 2020 Jul; 12(14):14649-14676. PubMed ID: 32723974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation markers associated with type 2 diabetes, fasting glucose and HbA
    Walaszczyk E; Luijten M; Spijkerman AMW; Bonder MJ; Lutgers HL; Snieder H; Wolffenbuttel BHR; van Vliet-Ostaptchouk JV
    Diabetologia; 2018 Feb; 61(2):354-368. PubMed ID: 29164275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Patterns in Blood Associated With Lipid Traits Predict Incident Coronary Heart Disease Events and Are Enriched for Results From Genome-Wide Association Studies.
    Hedman ÅK; Mendelson MM; Marioni RE; Gustafsson S; Joehanes R; Irvin MR; Zhi D; Sandling JK; Yao C; Liu C; Liang L; Huan T; McRae AF; Demissie S; Shah S; Starr JM; Cupples LA; Deloukas P; Spector TD; Sundström J; Krauss RM; Arnett DK; Deary IJ; Lind L; Levy D; Ingelsson E
    Circ Cardiovasc Genet; 2017 Jan; 10(1):e001487. PubMed ID: 28213390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance.
    Grasse S; Lienhard M; Frese S; Kerick M; Steinbach A; Grimm C; Hussong M; Rolff J; Becker M; Dreher F; Schirmer U; Boerno S; Ramisch A; Leschber G; Timmermann B; Grohé C; Lüders H; Vingron M; Fichtner I; Klein S; Odenthal M; Büttner R; Lehrach H; Sültmann H; Herwig R; Schweiger MR
    Genome Med; 2018 Jul; 10(1):55. PubMed ID: 30029672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.
    Sun X; Yi J; Yang J; Han Y; Qian X; Liu Y; Li J; Lu B; Zhang J; Pan X; Liu Y; Liang M; Chen E; Liu P; Lu Y
    Theranostics; 2021; 11(11):5346-5364. PubMed ID: 33859751
    [No Abstract]   [Full Text] [Related]  

  • 11. Epigenome-wide association study of smoking and DNA methylation in non-small cell lung neoplasms.
    Freeman JR; Chu S; Hsu T; Huang YT
    Oncotarget; 2016 Oct; 7(43):69579-69591. PubMed ID: 27602958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating Genome and Methylome Data to Identify Candidate DNA Methylation Biomarkers for Pancreatic Cancer Risk.
    Zhu J; Yang Y; Kisiel JB; Mahoney DW; Michaud DS; Guo X; Taylor WR; Shu XO; Shu X; Liu D; Li B; Tao R; Cai Q; Zheng W; Long J; Wu L
    Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2079-2087. PubMed ID: 34497089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenome-Wide Association Study Identifies Cardiac Gene Patterning and a Novel Class of Biomarkers for Heart Failure.
    Meder B; Haas J; Sedaghat-Hamedani F; Kayvanpour E; Frese K; Lai A; Nietsch R; Scheiner C; Mester S; Bordalo DM; Amr A; Dietrich C; Pils D; Siede D; Hund H; Bauer A; Holzer DB; Ruhparwar A; Mueller-Hennessen M; Weichenhan D; Plass C; Weis T; Backs J; Wuerstle M; Keller A; Katus HA; Posch AE
    Circulation; 2017 Oct; 136(16):1528-1544. PubMed ID: 28838933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenome-wide association study of incident type 2 diabetes: a meta-analysis of five prospective European cohorts.
    Fraszczyk E; Spijkerman AMW; Zhang Y; Brandmaier S; Day FR; Zhou L; Wackers P; Dollé MET; Bloks VW; Gào X; Gieger C; Kooner J; Kriebel J; Picavet HSJ; Rathmann W; Schöttker B; Loh M; Verschuren WMM; van Vliet-Ostaptchouk JV; Wareham NJ; Chambers JC; Ong KK; Grallert H; Brenner H; Luijten M; Snieder H
    Diabetologia; 2022 May; 65(5):763-776. PubMed ID: 35169870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prognostic DNA methylation signature for stage I non-small-cell lung cancer.
    Sandoval J; Mendez-Gonzalez J; Nadal E; Chen G; Carmona FJ; Sayols S; Moran S; Heyn H; Vizoso M; Gomez A; Sanchez-Cespedes M; Assenov Y; Müller F; Bock C; Taron M; Mora J; Muscarella LA; Liloglou T; Davies M; Pollan M; Pajares MJ; Torre W; Montuenga LM; Brambilla E; Field JK; Roz L; Lo Iacono M; Scagliotti GV; Rosell R; Beer DG; Esteller M
    J Clin Oncol; 2013 Nov; 31(32):4140-7. PubMed ID: 24081945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent Validation of Early-Stage Non-Small Cell Lung Cancer Prognostic Scores Incorporating Epigenetic and Transcriptional Biomarkers With Gene-Gene Interactions and Main Effects.
    Zhang R; Chen C; Dong X; Shen S; Lai L; He J; You D; Lin L; Zhu Y; Huang H; Chen J; Wei L; Chen X; Li Y; Guo Y; Duan W; Liu L; Su L; Shafer A; Fleischer T; Moksnes Bjaanæs M; Karlsson A; Planck M; Wang R; Staaf J; Helland Å; Esteller M; Wei Y; Chen F; Christiani DC
    Chest; 2020 Aug; 158(2):808-819. PubMed ID: 32113923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide DNA methylation at birth in relation to in utero arsenic exposure and the associated health in later life.
    Kaushal A; Zhang H; Karmaus WJJ; Everson TM; Marsit CJ; Karagas MR; Tsai SF; Wen HJ; Wang SL
    Environ Health; 2017 May; 16(1):50. PubMed ID: 28558807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide CpG island methylation analyses in non-small cell lung cancer patients.
    Heller G; Babinsky VN; Ziegler B; Weinzierl M; Noll C; Altenberger C; Müllauer L; Dekan G; Grin Y; Lang G; End-Pfützenreuter A; Steiner I; Zehetmayer S; Döme B; Arns BM; Fong KM; Wright CM; Yang IA; Klepetko W; Posch M; Zielinski CC; Zöchbauer-Müller S
    Carcinogenesis; 2013 Mar; 34(3):513-21. PubMed ID: 23172663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk.
    Yang Y; Wu L; Shu X; Lu Y; Shu XO; Cai Q; Beeghly-Fadiel A; Li B; Ye F; Berchuck A; Anton-Culver H; Banerjee S; Benitez J; Bjørge L; Brenton JD; Butzow R; Campbell IG; Chang-Claude J; Chen K; Cook LS; Cramer DW; deFazio A; Dennis J; Doherty JA; Dörk T; Eccles DM; Edwards DV; Fasching PA; Fortner RT; Gayther SA; Giles GG; Glasspool RM; Goode EL; Goodman MT; Gronwald J; Harris HR; Heitz F; Hildebrandt MA; Høgdall E; Høgdall CK; Huntsman DG; Kar SP; Karlan BY; Kelemen LE; Kiemeney LA; Kjaer SK; Koushik A; Lambrechts D; Le ND; Levine DA; Massuger LF; Matsuo K; May T; McNeish IA; Menon U; Modugno F; Monteiro AN; Moorman PG; Moysich KB; Ness RB; Nevanlinna H; Olsson H; Onland-Moret NC; Park SK; Paul J; Pearce CL; Pejovic T; Phelan CM; Pike MC; Ramus SJ; Riboli E; Rodriguez-Antona C; Romieu I; Sandler DP; Schildkraut JM; Setiawan VW; Shan K; Siddiqui N; Sieh W; Stampfer MJ; Sutphen R; Swerdlow AJ; Szafron LM; Teo SH; Tworoger SS; Tyrer JP; Webb PM; Wentzensen N; White E; Willett WC; Wolk A; Woo YL; Wu AH; Yan L; Yannoukakos D; Chenevix-Trench G; Sellers TA; Pharoah PDP; Zheng W; Long J
    Cancer Res; 2019 Feb; 79(3):505-517. PubMed ID: 30559148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients.
    Son JW; Jeong KJ; Jean WS; Park SY; Jheon S; Cho HM; Park CG; Lee HY; Kang J
    Cancer Lett; 2011 Dec; 311(1):29-37. PubMed ID: 21757291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.